Lupin has received tentative approval from the U.S. Food and Drug Administration (FDA) to market ivacaftor tablets, a generic…
Articles by Steve Bryson, PhD
Stool consistency and frequency were healthy for the majority of infants with cystic fibrosis (CF) in the first year…
A detailed analysis of lung tissue of cystic fibrosis (CF) patients found specific changes to the extracellular matrix (ECM),…
ReCode Therapeutics’ investigational aerosolized RNA-based therapies for cystic fibrosis (CF) restored CFTR function, the defective protein in CF,…
LungFit GO, inhaled nitric oxide (NO) that can be self-administered at home, was well tolerated and improved various quality…
For the first time, bacteriophages — viruses that kill bacteria — eliminated an antibiotic-resistant mycobacterial lung infection in a man…
Cases of severe COVID-19 remained low during the first year of the pandemic in people in France with cystic…
Some people with severe asthma, an inflammatory lung condition, carry variants of the CFTR gene that causes cystic fibrosis…
Triple combination therapies, a mix of CFTR correctors and potentiators, significantly improve lung function, reduce sweat chloride, and enhance the…
The first patient has been dosed in a Phase 1/2 clinical trial evaluating 4D-710, an investigational genetic medicine for adults…